SHERIDAN, WYOMING – July 22, 2025 – Globus Medical, Inc. has scheduled the announcement of its financial results for the second quarter ended June 30, 2025, for Thursday, August 7, 2025, after market close. The musculoskeletal technology leader will publish the earnings release on its investor relations website at www.investors.globusmedical.com.
Investor Call Scheduled for August 7
Following the earnings release, Globus Medical will host a teleconference with the investment community at 4:30 p.m. Eastern Time on the same day. The company offers multiple ways for stakeholders to join the event:
- Live webcast: Available on the Investors page of the Globus Medical website at https://www.investors.globusmedical.com/news-events/events-webcasts.
- Telephone participation: Interested parties must register in advance via a dedicated link. Upon registration, participants will receive a confirmation email with details on how to join, including the dial-in number, unique passcode, and registrant ID.
An audio archive of the call will be accessible on the Investors page after the event.
Committed to Innovation in Musculoskeletal Care
Globus Medical positions itself as a global leader in musculoskeletal technology, with a mission to solve unmet clinical needs and improve patient outcomes. The company’s portfolio spans:
- Spine solutions
- Orthopedic trauma
- Joint reconstruction
- Biomaterials
- Enabling technologies
With a focus on innovation, clinical education, and comprehensive support, Globus Medical continues to advance its leadership in the sector. Further company information is available at www.globusmedical.com.
Forward-Looking Statements Reflect Strategic Outlook
The company emphasized that forward-looking statements within its communications, including the earnings release, are based on current expectations and are subject to a range of risks and uncertainties. These include factors related to the integration of NuVasive and Nevro, market demand, competitive dynamics, product innovation, regulatory compliance, and broader industry trends.
As outlined by the company:
“All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as ‘believe,’ ‘may,’ ‘might,’ ‘could,’ ‘will,’ ‘aim,’ ‘estimate,’ ‘continue,’ ‘anticipate,’ ‘intend,’ ‘expect,’ ‘plan’ and other similar terms.”
Globus Medical advises stakeholders to consult its most recent filings with the U.S. Securities and Exchange Commission for a detailed discussion of risks and uncertainties, accessible at www.sec.gov.
Learn more at www.globusmedical.com.